Health Glance
Only time will tell whether or not there is an ulterior motive in regards to the new changes implemented by the EU and those proposed by the EPA. However, it is always good practice to assume that when you see different countries implementing the same policies at the same time, there is much more to the story than meets the eye.
America and EU Agree: Raise Radiation Levels for Food
Japan sets new radiation safety level for seafood
The government set its first radiation safety standards for fish Tuesday after Japan's tsunami-ravaged nuclear plant reported radioactive contamination in nearby seawater measuring at several million times the legal limit.
The new levels coupled with reports that radiation was building up in fish led the government to create an acceptable radiation standard for fish for the first time. Some fish caught Friday off Japan's coastal waters would have exceeded the new provisional limit.
Pampers Recalls 29,000 pacifiers
The Consumer Product Safety Commission and Key Baby LLC have announced a voluntary recall of about 29,000 Pampers Natural Stages Infant Ortho and Bulb Pacifiers because the 'pacifiers fail to meet federal safety standards and pose a choking hazard to young children.'
Specifically, Key Baby states that the width of the back plate of the pacifier doesn't meet standards on some of the pacifiers.
Pfizer, Lilly Antidepressants Linked to Narrowed Arteries in Older Men
Antidepressants may narrow the arteries of middle-aged men, potentially putting them at risk for heart attacks and stroke, researchers said.
A study involving 513 male twins, with an average age of 55, found those who took medications like Forest Laboratories Inc. (FRX)’s Lexapro, Eli Lilly & Co. (LLY)’s Cymbalta or Pfizer Inc. (PFE)’s Zoloft had thicker blood vessel walls. The increase, a measure of fatty-plaque buildup linked to atherosclerosis, was seen regardless of what type of antidepressant the men were taking.
FDA to allow cheaper preterm baby drug
The Food and Drug Administration on Wednesday disputed a drug company’s claim that pharmacies can no longer produce less expensive versions of a drug long used to reduce the risk that women will give birth prematurely.
The statement was aimed at defusing a controversy that erupted after the agency approved the drug Makena to prevent preterm births. Makena’s owner, KV Pharmaceutical of St. Louis, is charging $1,500 a dose for the drug. The same compound had been available for years for about $10 to $20 a dose.
Evidence ties smoking to throat, stomach cancer
Smokers face an increased risk of certain types of throat and stomach cancers, even years after they quit, a new study finds.
Combining the results of 33 past studies, Italian researchers found that current smokers were more than twice as likely as nonsmokers to develop cancer, either in their esophagus or in a part of the stomach called the gastric cardia.
In some of the studies, the risk of esophagus cancer remained high even when people had quit smoking three decades earlier.
J&J recalling more Tylenol from closed plant
Johnson & Johnson said it was recalling more than 700,000 bottles or packages of Tylenol and other consumer medicines made at a now-closed plant, the latest in a litany of recalls by the company.
J&J's McNeil Consumer Healthcare unit recalled one lot of Tylenol 8 Hour Extended Release Caplets, or 34,056 bottles, from retailers, the company said. The company cited a musty odor that has prompted many other J&J recalls. The product was made at its Fort Washington, Pennsylvania plant before J&J closed the facility in April 2010.
More Articles...
Page 113 of 234
